Antibody response to 17D yellow fever vaccine in Ghanaian infants

Bulletin of the World Health Organization

Volumn 79, Issue 11, 2001, Pages 1056-1059

  Osei Kwasi, M ^a   Dunyo, S K ^a   Koram, K A ^a   Afari, E A ^a   Odoom, J K ^a   Nkrumah, F K ^a  

^a University of Ghana   (Ghana)

Author keywords

Antibody formation immunology; Ghana; Infant; Randomized controlled trials; Yellow fever vaccine immunology adverse effects

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; NEUTRALIZING ANTIBODY; ORAL POLIOMYELITIS VACCINE; YELLOW FEVER VACCINE;

YELLOW FEVER;

ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; ENDEMIC DISEASE; FEMALE; FEVER; GHANA; HIGH RISK POPULATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SERUM; VACCINATION; VERO CELL; VOMITING; YELLOW FEVER;

ANTIBODIES, VIRAL; ANTIBODY FORMATION; GHANA; HUMANS; INCIDENCE; INFANT; YELLOW FEVER VACCINE;

EID: 0035172131     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Yellow fever in the Gambia, 1978-1979: Epidemiologic aspects with observations on the occurrence of Orungo virus infections
2. Yellow fever in 1983
3. Recent yellow fever epidemics in Ghana (1969-1983)
4. Urban yellow fever epidemic in western Nigeria, 1987
5. Yellow fever, 1996-1997
6. Yellow fever
7. Quibbling over yellow fever vaccine: Operational research issues
8. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: A randomized controlled trial in Ghana
9. A simple method of estimation of 50% endpoints